Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction AdenocarcinomaZhi Peng, Lin Shen, Jieer Ying et al.|Clinical Cancer Research|2021Cited by 119